Back

Glycaemic variability underlies myocyte dysfunction and myocardial injury risk in diabetes

Cao, Y.; Redd, M. A.; Outhwaite, J. E.; Mizikovsky, D.; Shim, W. J.; Fang, C.; Wu, Z.; Daygon, D.; Stark, T.; Palfreyman, R.; Chiu, H. S.; Tan, C.; Thomas, U.; Dragicevic, E.; Sng, J.; Barrett, H.; Dorey, E.; Shah, S.; Short, K.; Palpant, N. J.

2025-01-31 cell biology
10.1101/2025.01.29.635173 bioRxiv
Show abstract

Heart disease is the leading cause of morbidity and mortality in individuals with diabetes, due largely to risks associated with ischaemic injuries such as myocardial infarction (MI). We use human population genetic data to demonstrate that current biomarkers of hyperglycaemia do not account for risk of post-MI mortality in diabetes patients. This study therefore systematically evaluates glycaemic stress underpinning cardiovascular risk in diabetes. Using in vivo and in vitro models, we demonstrate that glycaemic variability rather than hyperglycaemia alone is a dominant risk factor for heart muscle dysfunction and myocardial injury sensitivity in diabetes. These findings provide new preclinical models for mechanistic and drug discovery studies and inform strategies for managing cardiovascular outcomes in patients with diabetes.

Published in Nature Communications (predicted rank #2) · training set

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.